JS Reis‐Filho

1.2k total citations
22 papers, 897 citations indexed

About

JS Reis‐Filho is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, JS Reis‐Filho has authored 22 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in JS Reis‐Filho's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (7 papers) and HER2/EGFR in Cancer Research (5 papers). JS Reis‐Filho is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (7 papers) and HER2/EGFR in Cancer Research (5 papers). JS Reis‐Filho collaborates with scholars based in United Kingdom, United States and France. JS Reis‐Filho's co-authors include Alan Ashworth, Sunil R. Lakhani, Alan Mackay, Kay Savage, Chris Jones, Kerry Fenwick, Schmitt Fc, Rachael Natrajan, Marjan Iravani and Anastasia Gabriel and has published in prestigious journals such as Cancer Research, The Journal of Pathology and Breast Cancer Research.

In The Last Decade

JS Reis‐Filho

21 papers receiving 880 citations

Peers

JS Reis‐Filho

ONCOL

PFM

GENET

Dawn Steele United Kingdom

Yasuyo Ohi Japan

Bradley Wubbenhorst United States

Narinder Tamber United Kingdom

Jarle B. Arnes Norway

Yoshiatsu Sagara Japan

D Steele United Kingdom

P.M. Wencyk United Kingdom

Kathy A. Toy United States

Shannon L. Puhalla United States

Dawn Steele United Kingdom

JS Reis‐Filho

398 ×1.0

256 ×0.6

410 ×1.1

ONCOL

127 ×0.5

PFM

95 ×0.6

GENET

Citations per year, relative to JS Reis‐Filho JS Reis‐Filho (= 1×) peers Dawn Steele

Countries citing papers authored by JS Reis‐Filho

Since Specialization

Citations

This map shows the geographic impact of JS Reis‐Filho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JS Reis‐Filho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JS Reis‐Filho more than expected).

Fields of papers citing papers by JS Reis‐Filho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JS Reis‐Filho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JS Reis‐Filho. The network helps show where JS Reis‐Filho may publish in the future.

Co-authorship network of co-authors of JS Reis‐Filho

This figure shows the co-authorship network connecting the top 25 collaborators of JS Reis‐Filho. A scholar is included among the top collaborators of JS Reis‐Filho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JS Reis‐Filho. JS Reis‐Filho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reis‐Filho, JS, et al.. (2019). Abstract P4-04-01: The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers. Cancer Research. 79(4_Supplement). P4–4. 1 indexed citations

Bottai, Giulia, Ahmed Nagy, L. Pusztai, et al.. (2017). Abstract P1-07-06: Immune signatures define and affect prognosis in triple-negative breast cancer subtypes. Cancer Research. 77(4_Supplement). P1–7. 1 indexed citations

Piscuoglio, Salvatore, Odette Mariani, Luciano G. Martelotto, et al.. (2016). Abstract P6-03-10: Genomic and transcriptomic heterogeneity in metaplastic breast carcinomas. Cancer Research. 76(4_Supplement). P6–3.

Powell, S.N., Naveeda Riaz, Salvatore Piscuoglio, et al.. (2016). Abstract S4-03: A functional assay for homologous recombination (HR) DNA repair and whole exome sequencing reveal that HR-defective sporadic breast cancers are enriched for genetic alterations in DNA repair genes. Cancer Research. 76(4_Supplement). S4–3. 3 indexed citations

Piscuoglio, Salvatore, P. Cottu, Larry Norton, et al.. (2013). Abstract S6-06: High-depth massively parallel sequencing reveals heterogeneity between primary tumor and metastatic deposits in de novo metastatic breast cancer patients prior to exposure to systemic therapy. Cancer Research. 73(24_Supplement). S6–6. 2 indexed citations

Piscuoglio, Salvatore, Rachael Natrajan, Odette Mariani, et al.. (2013). Abstract P4-04-08: Genomic and transcriptomic characterization of papillary carcinomas of the breast. Cancer Research. 73(24_Supplement). P4–4. 1 indexed citations

Gauthier, Anne-Sophie, Andrew R. Mackay, F Penault–Llorca, et al.. (2012). Abstract PD05-08: Genomic characterisation of invasive breast cancers with heterogeneous HER2 gene amplification. Cancer Research. 72(24_Supplement). PD05–8. 1 indexed citations

Wilkerson, Paul M, Daniel Wetterskog, David S.P. Tan, et al.. (2011). Preclinical evaluation of the PARP-inhibitor olaparib for the treatment of ovarian clear cell cancer. Geburtshilfe und Frauenheilkunde. 71(8). 1 indexed citations

Quinlan, Philip, et al.. (2010). Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis. Breast Cancer Research. 12(S1). 2 indexed citations

10.

Reis‐Filho, JS & Sunil R. Lakhani. (2008). Breast cancer special types: why bother?. The Journal of Pathology. 216(4). 394–398. 48 indexed citations

11.

Tan, David S.P., et al.. (2008). ESR1 amplification in endometrial carcinomas: hope or hyperbole?. The Journal of Pathology. 216(3). 271–274. 16 indexed citations

12.

Marchiò, Caterina, Rachael Natrajan, David S.P. Tan, et al.. (2008). The genomic profile of HER2‐amplified breast cancers: the influence of ER status. The Journal of Pathology. 216(4). 399–407. 64 indexed citations

13.

Simpson, Peter T., JS Reis‐Filho, Chris Jones, et al.. (2008). Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. The Journal of Pathology. 215(3). 231–244. 113 indexed citations

14.

Marchiò, Caterina, Marjan Iravani, Rachael Natrajan, et al.. (2008). Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. The Journal of Pathology. 215(4). 398–410. 115 indexed citations

15.

McCarthy, Afshan, et al.. (2007). A mouse model of basal‐like breast carcinoma with metaplastic elements. The Journal of Pathology. 211(4). 389–398. 110 indexed citations

16.

Esseghir, Selma, JS Reis‐Filho, Alan Kennedy, et al.. (2006). Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. The Journal of Pathology. 210(4). 420–430. 64 indexed citations

17.

Reis‐Filho, JS, Céline Pinheiro, Fernanda Milanezi, et al.. (2006). EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. The Journal of Pathology. 209(4). 445–453. 207 indexed citations

18.

Natrajan, Rachael, Alan Mackay, JS Reis‐Filho, et al.. (2006). Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. The Journal of Pathology. 210(1). 49–58. 98 indexed citations

19.

Natrajan, Rachael, Nayanta Sodha, JS Reis‐Filho, et al.. (2006). Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour. The Journal of Pathology. 211(1). 52–59. 47 indexed citations

20.

Reis‐Filho, JS, et al.. (2001). Reactive spindle cell nodules of the breast.. PubMed. 115(5). 781–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact